HomeCompareAPE vs JNJ

APE vs JNJ: Dividend Comparison 2026

APE yields 140.85% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APE wins by $35.1K in total portfolio value
10 years
APE
APE
● Live price
140.85%
Share price
$1.42
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55.1K
Annual income
$38.53
Full APE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — APE vs JNJ

📍 APE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APE
Annual income on $10K today (after 15% tax)
$11,971.83/yr
After 10yr DRIP, annual income (after tax)
$32.75/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $670.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APE + JNJ for your $10,000?

APE: 50%JNJ: 50%
100% JNJ50/50100% APE
Portfolio after 10yr
$37.6K
Annual income
$433.16/yr
Blended yield
1.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

APE
Analyst Ratings
2
Buy
6
Hold
7
Sell
Consensus: Sell
Altman Z
-1.2
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APE buys
0
JNJ buys
0
No recent congressional trades found for APE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPEJNJ
Forward yield140.85%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-50%5.8%
Portfolio after 10y$55.1K$20.0K
Annual income after 10y$38.53$827.78
Total dividends collected$21.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: APE vs JNJ ($10,000, DRIP)

YearAPE PortfolioAPE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$17,742$7,042.25$10,676$355.77+$7.1KAPE
2$24,823$5,838.57$11,407$389.39+$13.4KAPE
3$30,377$3,817.11$12,198$426.53+$18.2KAPE
4$34,687$2,182.84$13,056$467.62+$21.6KAPE
5$38,280$1,164.72$13,987$513.12+$24.3KAPE
6$41,560$600.63$14,998$563.56+$26.6KAPE
7$44,774$304.72$16,098$619.52+$28.7KAPE
8$48,061$153.40$17,295$681.69+$30.8KAPE
9$51,502$76.95$18,599$750.82+$32.9KAPE
10$55,146$38.53$20,022$827.78+$35.1KAPE

APE vs JNJ: Complete Analysis 2026

APEStock

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. As of March 1, 2022, it operated approximately 950 theatres and 10,600 screens. The company was founded in 1920 and is headquartered in Leawood, Kansas.

Full APE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this APE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APE vs SCHDAPE vs JEPIAPE vs OAPE vs KOAPE vs MAINAPE vs ABBVAPE vs MRKAPE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.